143 related articles for article (PubMed ID: 31116268)
21. MSH6 immunohistochemical heterogeneity in colorectal cancer: comparative sequencing from different tumor areas.
Chen W; Pearlman R; Hampel H; Pritchard CC; Markow M; Arnold C; Knight D; Frankel WL
Hum Pathol; 2020 Feb; 96():104-111. PubMed ID: 31783044
[TBL] [Abstract][Full Text] [Related]
22. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
24. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
25. Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.
Nunes BL; Jucá MJ; Gomes EG; Menezes HL; Costa HO; Matos D; Saad SS
Int J Biol Markers; 2009; 24(3):156-64. PubMed ID: 19787626
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma.
Losi L; Ponti G; Gregorio CD; Marino M; Rossi G; Pedroni M; Benatti P; Roncucci L; de Leon MP
Pathol Res Pract; 2006; 202(9):663-70. PubMed ID: 16860493
[TBL] [Abstract][Full Text] [Related]
28. Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma.
Gomes EG; Jucá MJ; de Menezes HL; Nunes BL; Costa H; Lima Fde O; Matos D
Acta Cir Bras; 2009; 24(4):303-10. PubMed ID: 19705030
[TBL] [Abstract][Full Text] [Related]
29. Relationship among p53, stage, and prognosis of large bowel cancer.
Nathanson SD; Linden MD; Tender P; Zarbo RJ; Jacobsen G; Nelson LT
Dis Colon Rectum; 1994 Jun; 37(6):527-34. PubMed ID: 8200229
[TBL] [Abstract][Full Text] [Related]
30. Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases.
Ivanecz A; Kavalar R; Palfy M; Pivec V; Sremec M; Horvat M; Potrč S
HPB (Oxford); 2014 Mar; 16(3):235-42. PubMed ID: 23509992
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic characteristics of resectable colorectal cancer with mismatch repair protein defects in Chinese population: Retrospective case series and literature review.
Li J; Xu Q; Luo C; Chen L; Ying J
Medicine (Baltimore); 2020 Jun; 99(24):e20554. PubMed ID: 32541478
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma.
Bao F; Panarelli NC; Rennert H; Sherr DL; Yantiss RK
Am J Surg Pathol; 2010 Dec; 34(12):1798-804. PubMed ID: 21107085
[TBL] [Abstract][Full Text] [Related]
33. [Clinical significance of epidermal growth factor receptor and thymidylate synthase expression in primary liver cancer].
Guo FY; Yang J; Xiong SM; Zhu MQ; Gao S; Li JP
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):666-669. PubMed ID: 30481863
[No Abstract] [Full Text] [Related]
34. Correlation between inducible nitric oxide synthase and cyclooxygenase-2 expression in human colorectal adenocarcinoma: a cross-sectional study.
Habibollahi P; Jamshidiha M; Daryani NE; Jahanzad I; Ghahremani MH; Ostad SN
Pathol Oncol Res; 2010 Sep; 16(3):327-35. PubMed ID: 20069397
[TBL] [Abstract][Full Text] [Related]
35. Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma.
Kaira K; Ohde Y; Nakagawa K; Okumura T; Murakami H; Takahashi T; Kondo H; Nakajima T; Endo M; Yamamoto N
Med Oncol; 2012 Sep; 29(3):1663-72. PubMed ID: 21948461
[TBL] [Abstract][Full Text] [Related]
36. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
[TBL] [Abstract][Full Text] [Related]
37. P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.
Liang JT; Huang KC; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Chang KJ
Int J Cancer; 2002 Feb; 97(4):451-7. PubMed ID: 11802206
[TBL] [Abstract][Full Text] [Related]
38. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
[TBL] [Abstract][Full Text] [Related]
39. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
[TBL] [Abstract][Full Text] [Related]
40. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma.
Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J
Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
